Miranda-Pettersen K, Morais-de-Jesus M, Daltro-Oliveira R, Duarte DAD, Teles C, Schinoni MI, Miranda-Scippa Á, Paraná R, Quarantini LC

Language: English
References: 22
Page: 310-316
PDF size: 98.33 Kb.

ABSTRACT

Introduction. Fatigue is an important clinical finding in the hepatitis virus chronic infection. However, the absence of scales to measure fatigue, translated and validated for Brazilian Portuguese, prevents access to information essential in clarifying specific clinical conditions in this population. Aim. The aim of this study was to determine the psychometric properties of the fatigue impact scale for daily use (D-FIS), in Brazilian Portuguese, for patients with the hepatitis C virus (HCV) and hepatitis B virus (HBV) chronic infection. Material and methods. In this cross-sectional study, the authors evaluated the D-FIS in 101 outpatients, followed at the reference hospital. The Mini International Neuropsychiatric Interview Brazilian (MINI PLUS) was used to identify psychiatric disorders, and the Short Form Health Survey 36-item (SF-36) to evaluate the self-reported quality of life. We also examined the impact of fatigue on the quality of life of this group of patients. Results. Relevant psychometric D-FIS results were: floor effect proved to be 1%; skewness was 0.46; item homogeneity was 0.59 and SEM (SD = 8.51) was 2.4. The Cronbach’s alpha was 0.920 and itemtotal correlation yielded coefficients ranging from 0.65 (item 1) to 0.85 (item 3). In a linear regression model, fatigue and depression influenced the self-reported quality of life. Conclusion. This study presents that the fatigue scale for daily use in Brazilian Portuguese can be considered a useful tool to verify the presence of fatigue in patients with the hepatitis viruses B and C.

REFERENCES

1. Pavan K, Schmidt K, Marangoni B, Mendes MF, Tilbery CP, Lianza S. Esclerose Multipla: Adaptação transcultural e validação da escala modificada de impacto da fadiga. Arq Neuropsiquiatr 2007; 65: 669-73.

2. Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000; 95: 760-7.

3. Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004; 56: 157-70.

4. Arnold LM. Understanding fatigue in major depressive disorder and other medical disorders. Psychosomatics 2008; 49: 185-90.

5. Fisk JD, Doble SE. Construction and validation of a fatigue impact scale for daily administration (D-FIS). Qual Life Res 2002; 11: 263-72.

6. Hassoun Z, Willems B, Deslauriers J, Nguyen BN, Huet PM. Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale. Dig Dis Sci 2002; 47: 2674-81.

7. Hilsabeck RC, Hassanein TI, Perry W. Biopsychosocial predictors of fatigue in chronic hepatitis C. J Psychosom Res 2005; 58: 173-8.

8. Marcellin F, Preau M, Ravaux I, Dellamonica P, Spire B, Carrieri MP. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. HIV Clin Trials 2007; 8: 320-7.

9. Prince MI, James OFW, Holland NP, Jones DEJ. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 2000; 32: 368-73.

10. Seaman K, Paterson BL, Vallis M, Hirsch G, Peltekian KM. Future directions for investigation of fatigue in chronic hepatitis C viral infection. Chronic Illness 2009; 5: 115-28.

11. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical Infectious Diseases 1994; 18: S79.

12. Frith J, Newton J. Fatigue impact scale. Occupational Medicine 2010; 60: 159.

13. Martinez-Martin P, Catalan MJ, Benito-Leon J, Moreno AO, Zamarbide I, Cubo E, van Blercon N, et al. Impact of fatigue in Parkinson’s disease: the Fatigue Impact Scale for Daily Use (D-FIS). Qual Life Res 2006; 15: 597-606.

14. Benito-Leon J, Martinez-Martin P, Frades B, Martinez-Gines ML, de Andres C, Meca-Lallana JE, Antiguedad AR, et al. Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS). Mult Scler 2007; 13: 645-51.

15. Amorim P. Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev Bras Psiquiatr 2000; 22: 106-15.

16. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reumatol 1999; 39: 143-50.

17. Lohr KN. Assessing health status and quality-of-life instruments: attributes and review criteria. Quality of Life Research 2002; 11: 193-205.

18. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000; 53: 459-68.

19. Garcia de Yebenes Prous MJ, Salvanes FR, Ortells LC. Responsiveness of outcome measures. Reumatologia Clinica [English edition] 2008; 4: 240-7.

20. Martins T, Narciso-Schiavon JLUZ, Schiavon LDEL. Epidemiologia da infeccao pelo virus da hepatite C. CEP:88704:900.

21. Karaivazoglou K, Iconomou G, Triantos C, Hyphantis T, Thomopoulos K, Lagadinou M, Gogos C, et al. Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQOL). Ann Hepatol 2010; 9: 419-27.

22. Bland JM, Altman DG. Statistics notes: Cronbach’s alpha. BMJ 1997; 314: 572.